Ibotenic Acid for Circuit-Resolved Neuroscience
2026-08-10
Ibotenic acid is an NMDA receptor agonist used to interrogate excitatory neurotransmission and generate experimentally controlled neural lesions. This guide connects its pharmacology and handling requirements with circuit-level lessons from a landmark mechanical allodynia study, while distinguishing validated evidence from practical assay extensions.
Losmapimod: A State-Aware p38 MAPK Guide
2026-08-09
Losmapimod and GW856553X are more than conventional p38 MAPK pathway probes. This article presents a state-aware framework for interpreting inhibition, kinase dephosphorylation, inflammation signaling modulation, and translational assay design.
PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks
2026-08-08
The reference study developed PEI-LSP-RA-PLGA, a double-layer PLGA nanoparticle adjuvant designed to combine sustained release, intestinal targeting, and immune regulation in H9N2-vaccinated chicks. The formulation enhanced serum IgG, intestinal IgA, cytokine responses, lymphocyte differentiation, and intestinal structure, while mechanistic analyses implicated CCR6/CCR9 chemokine signaling and Toll-like, NOD-like, and IgA-production pathways.
Trelagliptin Succinate: From Glycemia to Bone
2026-08-07
Trelagliptin succinate, also known as SYR-472 succinate, offers translational researchers more than a glucose-lowering tool. Its selective DPP-4 inhibition and AMPK–RUNX2 evidence create a disciplined framework for connecting metabolic control with osteoblast biology.
Elobixibat Hydrate: Precision Modulation of Gut Motility and
2026-08-07
Explore how Elobixibat hydrate, a leading ileal bile acid transporter inhibitor, enables precision modulation of gut motility and metabolic pathways. This article offers a mechanistic deep dive, unique translational insights, and protocol guidance distinct from prior reviews.
GTP Solution (100 mM): Enabling Precision mRNA Synthesis for
2026-08-06
Explore how GTP Solution (100 mM) empowers high-fidelity mRNA synthesis for advanced bladder cancer research. This article delivers a unique, in-depth analysis of guanosine-5'-triphosphate's scientific and practical impact, protocol optimization, and translational implications.
O-GlcNAcylation Regulates HUWE1-TfR1 Axis in Preeclampsia Fe
2026-08-06
This study delineates how O-GlcNAc modification of HUWE1 orchestrates the ubiquitination and degradation of transferrin receptor 1 (TfR1), thereby restraining ferroptosis and supporting trophoblast syncytialization in preeclampsia. The findings propose the O-GlcNAc–HUWE1–TfR1 pathway as a mechanistically precise target for placental dysfunction and iron-driven pathology.
Super-Enhancer–FOXA1–SLC7A11 Axis Controls Disulfidptosis in
2026-08-05
Kang et al. reveal that a super-enhancer regulates SLC7A11 via FOXA1, driving disulfidptosis and tumor progression in prostate cancer. This mechanistic insight identifies a novel epigenetic vulnerability and suggests new avenues for targeted research on cell death regulation in cancer.
Angiotensin II: Strategic Leverage for Vascular Remodeling M
2026-08-05
This article explores the mechanistic depth and translational potential of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in vascular research, offering strategic guidance for modeling hypertension, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy. Drawing on recent advances—including the therapeutic modulation of Ang II-induced injury by benzyl alcohol—this piece provides protocol insights, critical analysis of the competitive research landscape, and a forward-looking perspective for translational investigators. By contextualizing APExBIO's Angiotensin II within both foundational and emerging paradigms, we highlight actionable strategies that elevate experimental rigor and translational relevance beyond typical product overviews.
Radicicol: Advancing Hsp90 Inhibition in Translational Resea
2026-08-04
Explore how Radicicol, a potent Hsp90 inhibitor from APExBIO, enables precision control of cell fate, inflammation, and immune modulation. This article integrates mechanistic insights, strategic protocol guidance, and translational considerations—bridging bench discovery to next-generation therapeutic innovation.
Elobixibat Hydrate: Optimizing IBAT Inhibitor Workflows in G
2026-08-04
Elobixibat hydrate stands out as a highly selective ileal bile acid transporter inhibitor, empowering researchers to dissect and modulate enterohepatic and metabolic pathways in chronic constipation and metabolic disease models. This guide details robust experimental workflows, troubleshooting strategies, and translational insights for maximizing data quality with APExBIO’s Elobixibat hydrate.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual Fluorescence for Macro
2026-08-03
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers real-time, dual-fluorescence mRNA delivery and translation efficiency assays in macrophages. This article uniquely analyzes carbohydrate-targeted delivery, practical protocol design, and translational insights for advanced gene regulation.
3-Bromopyruvate Restores Cetuximab Sensitivity via Ferroptos
2026-08-03
This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes resistance in colorectal cancer cells by inducing autophagy-dependent ferroptosis and apoptosis. The findings highlight mechanistic links between FOXO3a signaling, cell death pathways, and therapeutic strategies for resistant CRC.
Applied Workflows with Ertugliflozin (PF-04971729) in Diabet
2026-08-02
Ertugliflozin (PF-04971729) stands out for its unparalleled selectivity in SGLT2 inhibition, enabling precise mechanistic modeling of renal glucose transport and cardiovascular endpoints. This guide delivers actionable protocols, troubleshooting insights, and evidence-based recommendations to optimize diabetes mellitus research and beyond.
Vitamin C Inhibits ROS/NF-κB Pathway to Delay Cochlear Cell
2026-08-01
This study demonstrates that vitamin C (ascorbic acid) significantly ameliorates D-galactose-induced senescence in cochlear hair cells by inhibiting the ROS/NF-κB signaling pathway. These findings highlight a novel mechanism by which vitamin C may help counteract age-related hearing loss and suggest new directions for targeted senescence interventions.
460 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page